RXO (NYSE:RXO) Price Target Lowered to $15.00 at UBS Group

RXO (NYSE:RXO) had its price objective lowered by stock analysts at UBS Group from $17.00 to $15.00 in a report released on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price objective indicates a potential upside of 22.30% from the stock’s previous close.

RXO has been the topic of a number of other research reports. Benchmark reiterated a “hold” rating on shares of RXO in a report on Wednesday, October 22nd. JPMorgan Chase & Co. boosted their price target on RXO from $15.00 to $16.00 and gave the company an “underweight” rating in a research report on Wednesday, October 8th. Cowen reaffirmed a “hold” rating on shares of RXO in a research note on Friday, August 8th. The Goldman Sachs Group dropped their target price on shares of RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a research report on Thursday, October 9th. Finally, Barclays cut their price target on shares of RXO from $17.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, RXO has an average rating of “Hold” and an average price target of $16.85.

RXO Trading Down 9.5%

Shares of RXO stock traded down $1.29 during mid-day trading on Friday, hitting $12.27. 1,396,788 shares of the stock were exchanged, compared to its average volume of 1,715,964. The stock has a market capitalization of $2.01 billion, a price-to-earnings ratio of -5.68, a price-to-earnings-growth ratio of 11.09 and a beta of 1.67. RXO has a twelve month low of $12.16 and a twelve month high of $31.11. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. The company has a 50-day simple moving average of $16.78 and a 200 day simple moving average of $16.02.

RXO (NYSE:RXO) last released its earnings results on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.02). RXO had a positive return on equity of 1.18% and a negative net margin of 5.45%.The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter last year, the company posted $0.05 earnings per share. The business’s quarterly revenue was up 34.6% compared to the same quarter last year. Research analysts forecast that RXO will post 0.31 EPS for the current year.

Institutional Trading of RXO

Large investors have recently bought and sold shares of the company. AlphaQuest LLC acquired a new position in shares of RXO during the second quarter worth $29,000. Geneos Wealth Management Inc. acquired a new position in RXO in the 1st quarter worth $30,000. Larson Financial Group LLC lifted its holdings in RXO by 1,990.2% in the 1st quarter. Larson Financial Group LLC now owns 1,714 shares of the company’s stock worth $33,000 after buying an additional 1,632 shares in the last quarter. CWM LLC boosted its position in RXO by 234.4% in the 1st quarter. CWM LLC now owns 1,876 shares of the company’s stock valued at $36,000 after buying an additional 1,315 shares during the last quarter. Finally, Jones Financial Companies Lllp grew its stake in shares of RXO by 27.0% during the third quarter. Jones Financial Companies Lllp now owns 3,298 shares of the company’s stock valued at $49,000 after acquiring an additional 701 shares in the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.